Volume 28, Issue 5, Pages (November 2015)

Slides:



Advertisements
Similar presentations
Deubiquitinases Sharpen Substrate Discrimination during Membrane Protein Degradation from the ER Zai-Rong Zhang, Juan S. Bonifacino, Ramanujan S. Hegde.
Advertisements

Bleach Activates a Redox-Regulated Chaperone by Oxidative Protein Unfolding J. Winter, M. Ilbert, P.C.F. Graf, D. Özcelik, U. Jakob Cell Volume 135, Issue.
Evolution of the Cancer Stem Cell Model Antonija Kreso, John E. Dick Cell Stem Cell Volume 14, Issue 3, Pages (March 2014) DOI: /j.stem
The Landscape of Microsatellite Instability in Colorectal and Endometrial Cancer Genomes Tae-Min Kim, Peter W. Laird, Peter J. Park Cell Volume 155, Issue.
Ribosome Rescue and Protein Quality Control in Concert
Volume 13, Issue 13, Pages R514-R516 (July 2003)
Diversity of Polyubiquitin Chains
Sugar Makes Fat by Talking to SCAP
NAD+ Supplementation as a Novel Approach to cURIng HCC?
Fatty Acid Metabolism Meets Organelle Dynamics
Antagonizing ClpP: A New Power Play in Targeted Therapy for AML
Peptides Signal Mitochondrial Stress
Elodie Pronier, Ross L. Levine  Cancer Cell 
Cellular Fatty Acid Metabolism and Cancer
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
Pascal Ferré, Fabienne Foufelle  Cell Metabolism 
Kidney Cancer: Now Available in a New Flavor
PINK1 and Parkin Flag Miro to Direct Mitochondrial Traffic
The Immunoproteasome Cleans up after Inflammation
Filling a GAP(DH) in Caspase-Independent Cell Death
Proteaphagy—Selective Autophagy of Inactive Proteasomes
Sumoylation Stabilizes Smoothened to Promote Hedgehog Signaling
Capturing VCP: Another Molecular Piece in the ALS Jigsaw Puzzle
A “Reductionist” View of Cardiomyopathy
Proteasomes: Machines for All Reasons
Double Repression in Jasmonate-Mediated Plant Defense
Cystic Fibrosis as a Disease of Misprocessing of the Cystic Fibrosis Transmembrane Conductance Regulator Glycoprotein  John R. Riordan  The American Journal.
Lucas T. Gray, Alan M. Weiner  Molecular Cell 
iRhoms: ERADicating the Messenger in Growth Control Signaling
An Argonaute Protein Directs Nuclear Xrn2 Function
Mismatch Repair-Deficient Cancers Are Targets for Anti-PD-1 Therapy
FAL1ing inside an Amplicon
A Ribosomal Perspective on Proteostasis and Aging
AML Therapy: Wake Up the Guardian and Cut Loose the Executioners
Drugging Chromatin in Cancer: Recent Advances and Novel Approaches
Killing Lymphoma with Smac-Mimetics: As Easy as ABC?
Considering the critical interface between tumor cells and stromal cells in the search for targets for anticancer therapy  Laurence Blavier, Yves A. DeClerck 
CFTR: New Members Join the Fold
Mitochondrial Sterol Oxidation Marks the Spot
Johannes van den Boom, Hemmo Meyer  Molecular Cell 
Mitochondria and Cancer
Sugarcoating ER Stress
Non-Oncogene Addiction and the Stress Phenotype of Cancer Cells
Tumor Metabolism: MAGE-A Proteins Help TRIM Turn Over AMPK
The Ubiquitin Proteasome System in Neurodegenerative Diseases
RNA Quality Control in Eukaryotes
DUB-le Trouble for Cell Survival
Vms1 Relieves a Mitochondrial Import Chokehold
Angelman Syndrome: Finding the Lost Arc
The Expanding Cosmos of Nuclear Receptor Coactivators
Ethylene Prunes Translation
Life, Death, and Ubiquitin: Taming the Mule
HSC Fate Is Tethered to Mitochondria
Coordination of Two Genomes by Mitochondrial Translational Plasticity
Guardians of the ERAD Galaxy
A Futile Battle? Protein Quality Control and the Stress of Aging
TFIID and MYB Share a Therapeutic Handshake in AML
FAL1ing inside an Amplicon
All Roads Lead to the Ribosome
The TRIP from ULF to ARF Cancer Cell
S-Nitrosylation at the Interface of Autophagy and Disease
Design Principles of Protein Biosynthesis-Coupled Quality Control
Transmissible Proteins: Expanding the Prion Heresy
The Tribble with APL: A New Road to Therapy
F.-Nora Vögtle, Chris Meisinger  Developmental Cell 
Gankyrin: An intriguing name for a novel regulator of p53 and RB
Kidney Cancer: Now Available in a New Flavor
Sugar Makes Fat by Talking to SCAP
Targeting Protein Stability with a Small Molecule
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
Presentation transcript:

Volume 28, Issue 5, Pages 550-552 (November 2015) In Search of a Cure for Proteostasis-Addicted Cancer: A AAA Target Revealed  Di Xia, Yihong Ye  Cancer Cell  Volume 28, Issue 5, Pages 550-552 (November 2015) DOI: 10.1016/j.ccell.2015.10.006 Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 1 Roles of p97 in the Cellular Protein Quality Control Network p97 collaborates with the proteasome in degradation of misfolded ER proteins (the ERAD pathway), defective translation products (ribosome-associated degradation), misfolded mitochondrial outer membrane proteins (mitochondria-associated degradation), and aberrant nuclear proteins (nuclear quality control). In ERAD and mitochondria-associated degradation, p97 uses energy from ATP hydrolysis to extract misfolded proteins out of the membrane and target them for proteasomal degradation. E3, ubiquitin ligase. In the case of ribosome-associated degradation, ribosome-associated p97 may release stalled translation product to facilitate their turnover. In the nucleus, p97 promotes turnover of aberrant nuclear proteins by acting as a chaperone to prevent substrate aggregation. Cancer Cell 2015 28, 550-552DOI: (10.1016/j.ccell.2015.10.006) Copyright © 2015 Elsevier Inc. Terms and Conditions